Search Results - "FERNER, R"

Refine Results
  1. 1

    Post‐mortem clinical pharmacology by Ferner, R. E.

    Published in British journal of clinical pharmacology (01-10-2008)
    “…Clinical pharmacology assumes that deductions can be made about the concentrations of drugs from a knowledge of the pharmacokinetic parameters in an…”
    Get full text
    Journal Article
  2. 2

    Systemic toxicity related to metal hip prostheses by Bradberry, S. M., Wilkinson, J. M., Ferner, R. E.

    Published in Clinical toxicology (Philadelphia, Pa.) (01-09-2014)
    “…Abstract Introduction. One in eight of all total hip replacements requires revision within 10 years, 60% because of wear-related complications. The bearing…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Crisis in the supply of medicines by Ferner, R E, Aronson, J K, Heneghan, C

    Published in BMJ (Online) (04-10-2019)
    “…Drug shortages have complex causes and important clinical and economic consequences…”
    Get full text
    Journal Article
  5. 5

    Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine by McDowell, Sarah E, Coleman, Jamie J, Ferner, R E

    Published in BMJ (20-05-2006)
    “…Abstract Objective To review the evidence for ethnic differences in susceptibility to adverse drug reactions (ADRs) to cardiovascular drugs. Design Systematic…”
    Get full text
    Journal Article
  6. 6

    [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study by Ferner, R. E., Golding, J. F., Smith, M., Calonje, E., Jan, W., Sanjayanathan, V., O'Doherty, M.

    Published in Annals of oncology (01-02-2008)
    “…Background: Malignant peripheral nerve sheath tumours (MPNSTs) are difficult to detect in neurofibromatosis 1 (NF1) individuals. The purpose was to evaluate…”
    Get full text
    Journal Article
  7. 7

    Adverse drug reactions in dermatology by Ferner, R. E.

    Published in Clinical and experimental dermatology (01-03-2015)
    “…Summary Adverse drug reactions (ADRs) – that is, unintended and harmful responses to medicines – are important to dermatologists because many present with…”
    Get full text
    Journal Article
  8. 8

    Communicating information about drug safety by Ferner, R E, Aronson, J K

    Published in BMJ (15-07-2006)
    “…It can be hard to interpret information about potential harms from drugs, whether through adverse effects or drug interactions. A simple visual coding system…”
    Get full text
    Journal Article
  9. 9

    In vitro activity of gepotidacin against urine isolates of Escherichia coli from outpatient departments in Germany by Kresken, Michael, Wohlfarth, Esther, Weikel, Chase, Butler, Deborah, Pfeifer, Yvonne, Werner, Guido

    Published in Journal of antimicrobial chemotherapy (01-02-2023)
    “…Escherichia coli is the leading pathogen of community-acquired urinary tract infections. Gepotidacin is a novel, bactericidal, first-in-class…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Late-onset optic pathway tumors in children with neurofibromatosis 1 by LISTERNICK, R, FERNER, R. E, PIERSALL, L, SHARIF, S, GUTMANN, D. H, CHARROW, J

    Published in Neurology (23-11-2004)
    “…Identification of new optic pathway tumors (OPTs) and progression of pre-existing OPTs in children with neurofibromatosis 1 (NF1) have been reported…”
    Get full text
    Journal Article
  12. 12

    Joining the DoTS: new approach to classifying adverse drug reactions by Aronson, J K, Ferner, R E

    Published in BMJ (22-11-2003)
    “…Examples of immunological reactions that are clearly dose dependent include hay fever in response to high pollen counts 5 ; the immunogenic response to…”
    Get full text
    Journal Article
  13. 13

    Adverse drug reactions by Ferner, R E

    Published in Medicine (Abingdon. 1995, UK ed.) (01-07-2016)
    “…Abstract Adverse drug reactions (ADRs) are important but often difficult to diagnose. They should be considered in the differential diagnosis of a wide range…”
    Get full text
    Journal Article
  14. 14

    Toxicity of mercury by LANGFORD, N. J, FERNER, R. E

    Published in Journal of human hypertension (01-10-1999)
    “…A ruling by the European Union heralds the demise of those useful clinical instruments, the mercury thermometer and the mercury sphygmomanometer. The new laws…”
    Get full text
    Journal Article
  15. 15

    Medication errors that have led to manslaughter charges by Ferner, R E

    Published in BMJ (11-11-2000)
    “…The doctor was convicted. 4 Case no Doctor's origin Doctor's age and sex * Position Patient's age and sex Where death occurred Agent Nature of problem [dagger]…”
    Get full text
    Journal Article
  16. 16

    Further genotype - phenotype correlations in neurofibromatosis 2 by Selvanathan, SK, Shenton, A, Ferner, R, Wallace, AJ, Huson, SM, Ramsden, RT, Evans, DG

    Published in Clinical genetics (01-02-2010)
    “…Selvanathan SK, Shenton A, Ferner R, Wallace AJ, Huson SM, Ramsden RT, Evans DG. Further genotype–phenotype correlations in neurofibromatosis 2…”
    Get full text
    Journal Article
  17. 17

    The influence of big pharma by Ferner, R E

    Published in BMJ (16-04-2005)
    “…A report published last week on "the influence of the pharmaceutical industry" describes a strong United Kingdom pharmaceutical industry, whose net exports are…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs) by Upadhyaya, M, Kluwe, Lan, Spurlock, G, Monem, Bisma, Majounie, E, Mantripragada, K, Ruggieri, Martino, Chuzhanova, N, Evans, D.G, Ferner, R, Thomas, N, Guha, A, Mautner, V

    Published in Human mutation (2008)
    “…About 10% of neurofibromatosis type 1 (NF1) patients develop malignant peripheral nerve sheath tumors (MPNSTs) and represent considerable patient morbidity and…”
    Get full text
    Journal Article
  20. 20